Related Articles
Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer
Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma
Expression of ACP6 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma
A novel gene, RSRC2, inhibits cell proliferation and affects survival in esophageal cancer patients
High expression of special AT‑rich sequence binding protein‑1 predicts esophageal squamous cell carcinoma relapse and poor prognosis